This inventor holds 3 USPTO granted patents. Top assignee: Kringle Pharma Inc.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Ken-ichi Ito: Innovator in Organ Transplantation
Introduction
Ken-ichi Ito is a notable inventor based in Matsumoto, Japan. He has made significant contributions to the field of organ transplantation, particularly through his innovative pharmaceutical preparations. With a total of 3 patents to his name, Ito's work focuses on improving the outcomes of organ transplants.
Latest Patents
One of Ken-ichi Ito's latest patents is a fibrosis inhibitor for implanted organs. This pharmaceutical preparation comprises a hepatocyte growth factor or a DNA molecule encoding the same. The invention aims to suppress the fibrosis of a transplanted organ after organ transplantation. This advancement is particularly useful in the fields of organ transplantation and regeneration therapy.
Career Highlights
Ken-ichi Ito is associated with Kringle Pharma Inc., where he continues to develop innovative solutions for organ transplantation. His work has the potential to significantly enhance the success rates of organ transplants and improve patient outcomes.
Collaborations
Some of his notable coworkers include Jun Amano and Kazuhiro Yamaura. Their collaborative efforts contribute to the ongoing research and development in the field of organ transplantation.
Conclusion
Ken-ichi Ito's contributions to the field of organ transplantation through his innovative patents highlight his commitment to improving medical outcomes. His work continues to pave the way for advancements in regenerative therapy and organ transplant success.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile